Having joined IMARC in 2010, Kelly Schindelholz is currently IMARC’s Director of Clinical Monitoring Services. Kelly’s experience at IMARC includes devices used in the treatment peripheral vascular disease, iliofemoral venous and iliac artery disease, pulmonary embolism, in vitro diagnostics, aortic dissection and thoracic aneurysm treatments.
Before her work at IMARC, Kelly worked at University Hospitals Case Medical Center, Department of Dermatology. There she conducted in-vitro susceptibility testing of numerous infectious agents including: bacterial, fungal and yeast infections, aided in the development of new experimental methods, performed data analysis for projects, and assisted the in-vivo team during the second stage of the trials. Kelly has also worked as a Research Biologist in the Toxicology Department of Wil Research Laboratories.
Kelly has earned CCRA credentials through the Association of Clinical Research Professionals (ACRP). She has her Bachelor of Science Degree in Biology from the University of Akron, OH.